New Research Results – Safety of Short-Term Cultivated CAR T Cells in Cancer Immunotherapy
Short-term cultivated, individualised immune cells (CAR T cells) are currently being developed as a therapeutic option for patients with blood cancer. A research team from the Paul-Ehrlich-Institut…
